SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated

SBC
SBC Medical Group Holdings IncorporatedUS flagNASDAQ Global Market
3.04
USD
-0.04
- -
312.65MMarket Cap

Income Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
174
194
205
174
+ Sales & Services Revenue
174
194
205
174
- Cost of Revenue
59
56
49
46
+ Cost of Goods & Services
59
56
49
46
Gross Profit
115
137
156
127
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
93
66
71
60
+ Selling, General & Admin
93
66
71
60
+ Research & Development
- -
- -
- -
- -
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
21
71
85
67
- Non-Operating (Income) Loss
-2
-3
12
-15
+ Interest Expense, Net
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
-2
-2
12
-15
Pretax Income
24
74
73
82
- Income Tax Expense (Benefit)
18
35
27
31
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
6
39
47
51
- Net Extraordinary Losses (Gains)
-2
-2
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
-2
-2
- -
- -
Income (Loss) Incl. MI
7
40
47
51
- Minority Interest
1
1
- -
- -
Net Income, GAAP
6
39
47
51
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
6
39
47
51
EBIT
21
71
85
67
EBITDA
27
83
89
70
EBITDA Margin (%)
15.66
43.05
43.41
40.42
EBITA
21
71
85
67
Gross Margin (%)
65.94
70.94
75.97
73.32
Operating Margin (%)
12.26
36.72
41.56
38.87
Profit Margin (%)
3.63
20.34
22.69
29.37
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
6
12
4
3
Basic Weighted Avg Shares
101
101
97
103
Basic EPS, GAAP
0.06
0.39
0.48
0.5
Basic EPS from Cont Ops
0.06
0.38
0.48
0.5
Diluted Weighted Avg Shares
101
101
97
103
Diluted EPS, GAAP
0.06
0.39
0.48
0.5
Diluted EPS from Cont Ops
0.06
0.38
0.48
0.5

Balance Sheet (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
113
166
184
231
+ Cash, Cash Equivalents & STI
54
103
125
164
+ Cash & Cash Equivalents
52
103
125
164
+ ST Investments
2
- -
- -
- -
+ Accounts & Notes Receiv
44
53
48
53
+ Accounts Receivable, Net
13
35
30
30
+ Notes Receivable, Net
- -
1
- -
- -
+ Loans Receivable, Net
- -
8
10
9
+ Other Receivable, Net
31
9
8
14
+ Inventories
1
3
1
3
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
1
3
1
3
+ Other ST Assets
14
7
10
11
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
113
93
82
149
+ Property, Plant & Equip, Net
22
20
14
16
+ Property, Plant & Equip
57
30
25
25
- Accumulated Depreciation
36
11
11
9
+ LT Investments & Receivables
1
21
21
39
+ LT Investments
1
21
21
39
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
90
53
47
93
+ Total Intangible Assets
11
23
6
63
+ Goodwill
4
4
5
15
+ Other Intangible Assets
7
20
2
48
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
79
29
41
30
Total Assets
225
259
266
380
+ Payables & Accruals
37
59
44
35
+ Accounts Payable
15
27
15
18
+ Accrued Taxes
12
23
23
11
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
11
10
6
7
+ ST Debt
8
7
4
14
+ ST Borrowings
5
4
- -
9
+ ST Finance Leases
3
4
4
5
+ Other ST Liabilities
56
26
13
12
+ Deferred Revenue
30
25
13
7
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
25
1
- -
5
Total Current Liabilities
101
92
61
61
+ LT Debt
8
15
8
38
+ LT Borrowings
6
13
7
34
+ LT Finance Leases
2
2
1
4
+ Other LT Liabilities
8
7
2
18
+ Accrued Liabilities
7
6
1
16
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
1
1
1
2
Total Noncurrent Liabilities
16
23
10
56
Total Liabilities
118
115
71
117
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
27
37
63
73
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
27
37
63
73
- Treasury Stock
- -
- -
3
8
+ Retained Earnings
103
143
189
240
+ Other Equity
-25
-38
-54
-57
Equity Before Minority Interest
105
142
195
248
+ Minority/Non Controlling Interest
3
2
- -
15
Total Equity
108
144
195
263
Total Liabilities & Equity
225
259
266
380
Shares Outstanding
101
101
103
103
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
6
6
6
9
Net Debt
-41
-86
-118
-121
Net Debt to Equity
-38.43
-60.14
-60.72
-45.93
Tangible Common Equity Ratio
45.12
51.16
72.66
63.08
Current Ratio
1.12
1.79
3.01
3.78
Cash Conversion Cycle
- -
-71.87
-81.86
-43.17

Cash Flow Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
6
39
47
51
+ Depreciation & Amortization
6
12
4
3
+ Non-Cash Items
-1
8
17
-3
+ Stock-Based Compensation
- -
- -
13
- -
+ Deferred Income Taxes
-4
4
-14
5
+ Asset Impairment Charge
1
- -
16
- -
+ Other Non-Cash Adj
2
3
3
-8
+ Chg in Non-Cash Work Cap
-11
-8
-47
-27
+ (Inc) Dec in Accts Receiv
-10
-6
13
4
+ (Inc) Dec in Inventories
-1
-2
1
- -
+ (Inc) Dec in Prepaid Assets
-6
1
- -
1
+ Inc (Dec) in Accts Payable
17
8
-45
-20
+ Inc (Dec) in Other
-12
-8
-16
-11
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
- -
51
21
25
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
2
8
- -
7
+ Disp of Fixed Prod Assets
2
8
- -
7
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
-25
-11
-3
-3
+ Acq of Fixed Prod Assets
-25
-10
-3
-3
+ Acq of Intangible Assets
- -
-2
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
-5
+ Increase in Capital Stock
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
-5
+ Net Change in LT Investment
-3
2
- -
-1
+ Dec in LT Investment
- -
4
- -
- -
+ Inc in LT Investment
-3
-2
- -
-1
+ Net Cash From Acq & Div
-6
1
-5
-43
+ Cash from Divestitures
- -
1
- -
- -
+ Cash for Acq of Subs
-6
- -
-5
-43
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
-1
2
-1
18
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
-33
2
-10
-21
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
-5
4
12
33
+ Cash From Debt
- -
12
12
35
+ Repayments of Debt
-5
-9
- -
-2
+ Other Financing Activities
-3
3
11
10
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
-8
6
23
38
Effect of Foreign Exchange Rates
-12
-7
-11
-3
Net Changes in Cash
-41
59
33
42
EBITDA
27
83
89
70
EBITDA Margin (%)
15.66
43.05
43.41
40.42
Free Cash Flow
-25
39
17
22
Net Cash Paid for Acquisitions
6
-1
5
43
Free Cash Flow to Firm
-25
39
17
22
Free Cash Flow to Equity
- -
53
29
63
Free Cash Flow per Basic Share
-0.25
0.39
0.18
0.21
Price/Free Cash Flow
41.27
17.53
22.38
16.22
Cash Flow to Net Income
-0.01
1.29
0.44
0.48
Capital Expenditures
-25
-11
-3
-3